Should postmenopausal women be given estrogen?
作者信息
Haber R J
出版信息
West J Med. 1985 May;142(5):672-7.
Abstract
摘要
相似文献
1
Should postmenopausal women be given estrogen?绝经后女性应该服用雌激素吗？
West J Med. 1985 May;142(5):672-7.
2
Prevention of postmenopausal osteoporosis by estrogen/gestagen substitution therapy.
Med Klin (Munich). 1987 Mar 20;82(6):238-41.
3
Physicians changing postmenopausal sex hormone prescribing regimens.
Prog Clin Biol Res. 1986;216:325-35.
4
Current status of menopause and postmenopausal estrogen therapy.
Obstet Gynecol Surv. 1977 Apr;32(4):193-204. doi: 10.1097/00006254-197704000-00001.
5
[General undifferentiated estrogen (progestagen) substitution in the prevention of osteoporosis: contra].[普通未分化雌激素（孕激素）替代疗法预防骨质疏松症：反对意见]
Med Klin (Munich). 1987 Mar 20;82(6):241-4.
6
Hormone replacement therapy and cancer.
Br J Hosp Med. 1989 Feb;41(2):142, 144-6, 148-9.
7
Benefits and risks of estrogen replacement therapy in the menopause.更年期雌激素替代疗法的益处与风险。
Del Med J. 1984 Apr;56(4):209-18.
8
Estrogen replacement therapy.雌激素替代疗法
Adv Clin Care. 1991 Jul-Aug;6(4):5.
9
Is estrogen replacement therapy necessary?
J Reprod Med. 1985 Oct;30(10 Suppl):797-801.
10
[Substitute estrogen treatment of women after the menopause from the internist's viewpoint].[从内科医生视角看绝经后女性的雌激素替代治疗]
Pol Tyg Lek. 1985 Jul 29;40(30):852-4.
引用本文的文献
1
On the 'blackness' and 'whiteness' of patients.关于患者的“黑”与“白”。
West J Med. 1985 Oct;143(4):531-2.
2
Prevention of osteoporosis and osteoporotic fractures.
West J Med. 1985 Nov;143(5):684-7.
本文引用的文献
1
2
The risk of hip fracture in postmenopausal females with or without estrogen drug exposure.有或没有接触雌激素药物的绝经后女性发生髋部骨折的风险。
Am J Public Health. 1981 Feb;71(2):138-44. doi: 10.2105/ajph.71.2.138.
3
Predominance of early endometrial cancers after long-term estrogen use.长期使用雌激素后早期子宫内膜癌占优势。
JAMA. 1980 Nov 28;244(21):2419-22.
4
Epidemiology of fractures of the proximal femur in Rochester, Minnesota.明尼苏达州罗切斯特市股骨近端骨折的流行病学研究。
Clin Orthop Relat Res. 1980 Jul-Aug(150):163-71.
5
Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.孕激素与口服避孕药相关的心血管反应以及50微克和30微克雌激素制剂安全性的比较。
Br Med J. 1980 May 10;280(6224):1157-61. doi: 10.1136/bmj.280.6224.1157.
6
Use of postmenopausal hormones and risk of myocardial infarction.绝经后激素的使用与心肌梗死风险
Circulation. 1981 Jul;64(1):42-6. doi: 10.1161/01.cir.64.1.42.
7
Calcium intake requirement and bone mass in the elderly.老年人的钙摄入量需求与骨量
J Lab Clin Med. 1982 Sep;100(3):309-12.
8
Survival among women with endometrial cancer: a comparison of estrogen users and nonusers.子宫内膜癌女性的生存率：雌激素使用者与非使用者的比较。
Am J Obstet Gynecol. 1982 Jul 1;143(5):569-73. doi: 10.1016/0002-9378(82)90549-x.
9
The menopause: benefits and risks of estrogen-progestogen replacement therapy.更年期：雌激素 - 孕激素替代疗法的益处与风险
Fertil Steril. 1982 Apr;37(4):457-74. doi: 10.1016/s0015-0282(16)46149-2.
10
Endocrine problems in the menopause.更年期的内分泌问题。
Clin Obstet Gynecol. 1982 Mar;25(1):19-38. doi: 10.1097/00003081-198203000-00005.
Zotero 插件